Market revenue in 2023 | USD 17.9 million |
Market revenue in 2030 | USD 38.0 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Adeno-associated virus (aav) |
Fastest growing segment | Adeno-associated virus (AAV) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids |
Key market players worldwide | Merck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Adeno-associated virus (aav) was the largest segment with a revenue share of 20.11% in 2023. Horizon Databook has segmented the South Africa viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa is predicted to witness a rise in the market for manufacturing plasmid DNAs. To encourage the development of the biotechnology sector in the country, the South African government is taking major initiatives.
The Department of Science and Technology, which the South African government founded, has the responsibility for fostering and assisting in R&D in the field of biotechnology. Some of the key players operating in the viral vectors and plasmid DNA manufacturing market in South Africa include Cape Bio Pharms, Prodigy Biotech, and Biotech Laboratories.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account